Single Ascending Dose (SAD) and Multiple Ascending Dose (MAD) Study of M5049 in Healthy Participants
Clinical trial NCT03676322 · COMPLETED
Trial details
- NCT number
- NCT03676322
- Sponsor
- Merck KGaA, Darmstadt, Germany
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-09-20
- Primary completion
- 2019-07-26
- Enrollment
- 96
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.